Report Detail

Pharma & Healthcare Global Bio Simulation Market Insights, Forecast to 2025

  • RnM2708121
  • |
  • 06 May, 2019
  • |
  • Global
  • |
  • 111 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Biosimulation is computer-aided mathematical simulation of biological processes and systems and thus is an integral part of systems biology.
The global Bio Simulation market is valued at 1100 million US$ in 2018 and will reach 3360 million US$ by the end of 2025, growing at a CAGR of 15.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Bio Simulation market based on company, product type, end user and key regions.

This report studies the global market size of Bio Simulation in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Bio Simulation in these regions.
This research report categorizes the global Bio Simulation market by top players/brands, region, type and end user. This report also studies the global Bio Simulation market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Certara
Simulation Plus
Dassault Systèmes SA
Medtronic
Advanced Chemistry Development
Chemical Computing Group
Entelos Holding Corporation
Genedata AG
Physiomics PLC
Rhenovia Pharma

Market size by Product
For Drug Development
For Drug Discovery
Other
Market size by End User
Pharmaceutical and Biotechnology Companies
Academic and Government Research Institutes
Contract Research Organizations
Regulatory Authorities
Other End Users

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Bio Simulation market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Bio Simulation market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Bio Simulation companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Bio Simulation submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Bio Simulation are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Bio Simulation market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Bio Simulation Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Bio Simulation Market Size Growth Rate by Product
      • 1.4.2 For Drug Development
      • 1.4.3 For Drug Discovery
      • 1.4.4 Other
    • 1.5 Market by End User
      • 1.5.1 Global Bio Simulation Market Size Growth Rate by End User
      • 1.5.2 Pharmaceutical and Biotechnology Companies
      • 1.5.3 Academic and Government Research Institutes
      • 1.5.4 Contract Research Organizations
      • 1.5.5 Regulatory Authorities
      • 1.5.6 Other End Users
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Bio Simulation Market Size
      • 2.1.1 Global Bio Simulation Revenue 2014-2025
      • 2.1.2 Global Bio Simulation Sales 2014-2025
    • 2.2 Bio Simulation Growth Rate by Regions
      • 2.2.1 Global Bio Simulation Sales by Regions
      • 2.2.2 Global Bio Simulation Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Bio Simulation Sales by Manufacturers
      • 3.1.1 Bio Simulation Sales by Manufacturers
      • 3.1.2 Bio Simulation Sales Market Share by Manufacturers
      • 3.1.3 Global Bio Simulation Market Concentration Ratio (CR5 and HHI)
    • 3.2 Bio Simulation Revenue by Manufacturers
      • 3.2.1 Bio Simulation Revenue by Manufacturers (2014-2019)
      • 3.2.2 Bio Simulation Revenue Share by Manufacturers (2014-2019)
    • 3.3 Bio Simulation Price by Manufacturers
    • 3.4 Bio Simulation Manufacturing Base Distribution, Product Types
      • 3.4.1 Bio Simulation Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Bio Simulation Product Type
      • 3.4.3 Date of International Manufacturers Enter into Bio Simulation Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Bio Simulation Sales by Product
    • 4.2 Global Bio Simulation Revenue by Product
    • 4.3 Bio Simulation Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Bio Simulation Breakdown Data by End User

    6 North America

    • 6.1 North America Bio Simulation by Countries
      • 6.1.1 North America Bio Simulation Sales by Countries
      • 6.1.2 North America Bio Simulation Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Bio Simulation by Product
    • 6.3 North America Bio Simulation by End User

    7 Europe

    • 7.1 Europe Bio Simulation by Countries
      • 7.1.1 Europe Bio Simulation Sales by Countries
      • 7.1.2 Europe Bio Simulation Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Bio Simulation by Product
    • 7.3 Europe Bio Simulation by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Bio Simulation by Countries
      • 8.1.1 Asia Pacific Bio Simulation Sales by Countries
      • 8.1.2 Asia Pacific Bio Simulation Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Bio Simulation by Product
    • 8.3 Asia Pacific Bio Simulation by End User

    9 Central & South America

    • 9.1 Central & South America Bio Simulation by Countries
      • 9.1.1 Central & South America Bio Simulation Sales by Countries
      • 9.1.2 Central & South America Bio Simulation Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Bio Simulation by Product
    • 9.3 Central & South America Bio Simulation by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Bio Simulation by Countries
      • 10.1.1 Middle East and Africa Bio Simulation Sales by Countries
      • 10.1.2 Middle East and Africa Bio Simulation Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Bio Simulation by Product
    • 10.3 Middle East and Africa Bio Simulation by End User

    11 Company Profiles

    • 11.1 Certara
      • 11.1.1 Certara Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Certara Bio Simulation Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Certara Bio Simulation Products Offered
      • 11.1.5 Certara Recent Development
    • 11.2 Simulation Plus
      • 11.2.1 Simulation Plus Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Simulation Plus Bio Simulation Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Simulation Plus Bio Simulation Products Offered
      • 11.2.5 Simulation Plus Recent Development
    • 11.3 Dassault Systèmes SA
      • 11.3.1 Dassault Systèmes SA Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Dassault Systèmes SA Bio Simulation Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Dassault Systèmes SA Bio Simulation Products Offered
      • 11.3.5 Dassault Systèmes SA Recent Development
    • 11.4 Medtronic
      • 11.4.1 Medtronic Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Medtronic Bio Simulation Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Medtronic Bio Simulation Products Offered
      • 11.4.5 Medtronic Recent Development
    • 11.5 Advanced Chemistry Development
      • 11.5.1 Advanced Chemistry Development Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Advanced Chemistry Development Bio Simulation Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Advanced Chemistry Development Bio Simulation Products Offered
      • 11.5.5 Advanced Chemistry Development Recent Development
    • 11.6 Chemical Computing Group
      • 11.6.1 Chemical Computing Group Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Chemical Computing Group Bio Simulation Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Chemical Computing Group Bio Simulation Products Offered
      • 11.6.5 Chemical Computing Group Recent Development
    • 11.7 Entelos Holding Corporation
      • 11.7.1 Entelos Holding Corporation Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Entelos Holding Corporation Bio Simulation Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Entelos Holding Corporation Bio Simulation Products Offered
      • 11.7.5 Entelos Holding Corporation Recent Development
    • 11.8 Genedata AG
      • 11.8.1 Genedata AG Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Genedata AG Bio Simulation Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Genedata AG Bio Simulation Products Offered
      • 11.8.5 Genedata AG Recent Development
    • 11.9 Physiomics PLC
      • 11.9.1 Physiomics PLC Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Physiomics PLC Bio Simulation Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Physiomics PLC Bio Simulation Products Offered
      • 11.9.5 Physiomics PLC Recent Development
    • 11.10 Rhenovia Pharma
      • 11.10.1 Rhenovia Pharma Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Rhenovia Pharma Bio Simulation Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Rhenovia Pharma Bio Simulation Products Offered
      • 11.10.5 Rhenovia Pharma Recent Development

    12 Future Forecast

    • 12.1 Bio Simulation Market Forecast by Regions
      • 12.1.1 Global Bio Simulation Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Bio Simulation Revenue Forecast by Regions 2019-2025
    • 12.2 Bio Simulation Market Forecast by Product
      • 12.2.1 Global Bio Simulation Sales Forecast by Product 2019-2025
      • 12.2.2 Global Bio Simulation Revenue Forecast by Product 2019-2025
    • 12.3 Bio Simulation Market Forecast by End User
    • 12.4 North America Bio Simulation Forecast
    • 12.5 Europe Bio Simulation Forecast
    • 12.6 Asia Pacific Bio Simulation Forecast
    • 12.7 Central & South America Bio Simulation Forecast
    • 12.8 Middle East and Africa Bio Simulation Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Bio Simulation Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Bio Simulation . Industry analysis & Market Report on Bio Simulation is a syndicated market report, published as Global Bio Simulation Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Bio Simulation market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,069.30
      4,603.95
      6,138.60
      3,591.90
      5,387.85
      7,183.80
      608,712.00
      913,068.00
      1,217,424.00
      324,948.00
      487,422.00
      649,896.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report